CAS 2379-55-7 - China Manufacturers, Factory, Suppliers

CAS 2379-55-7, , , ,. The product will supply to all over the world, such as Europe, America, Australia,, ,, .

Related Products

2,3-Dimethylquinoxaline CAS 2379-55-7 Purity 98.0 (GC) (T) Factory Shanghai Ruifu Chemical Co., Ltd. www.ruifuchem.com — 2,3-Dimethylquinoxaline CAS 2379-55-7 Purity >97.0% (GC) (T)
Read More

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

L-Menthol CAS 2216-51-5 Purity >99.5% (GC) Factory

tert-Butylhydroquinone (TBHQ) CAS 1948-33-0 Purity >99.5% (GC) Food Antioxidant Factory

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Top Selling Products

Related Blog
Reviews

The Nobel Prize in Chemistry 2021 Benjamin List and David W.C. MacMillan

6 October 2021 The Royal Swedish Academy of Sciences has decided to award the Nobel Prize in Chemistry 2021 to Benjamin List Max-Planck-Institut für Kohlenforschung, Mülheim an der Ruhr, Germany Da...
New COVID treatments offer hope

Scientists around the world have made promising breakthroughs in developing a cure for COVID-19. Among new developments include antiviral pills and antibody compounds. As more countries look to ado...
Xi presents award to top scientists

President Xi Jinping, also general secretary of the Communist Party of China (CPC) Central Committee and chairman of the Central Military Commission, presents China’s top science award to a...
The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

The 3rd CMC-China 2021 Time: September 29-30, 2021 Exhibition Venue: C-D Hall, Suzhou International Expo Center, Suzhou City, JIangsu Province, China. Synergy of Centralized China’s Drug Volume-ba...
Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adult...
The “Summit on COVID-19 Diagnostics & Treatment”

The “Summit on COVID-19 Diagnostics & Treatment” September 27-29, 2021 at China International Exhibition Center (Tianzhu New Hall), Beijing. The outbreak of Corona Virus Disease 2019 (...

2022.12.04 19:03:06
2022.03.15 17:10:36
2022.02.28 14:46:52
2022.01.28 03:56:33
2021.12.08 23:08:30
2021.12.07 09:26:03

CAS 2379-55-7 - China Manufacturers, Factory, Suppliers

Related Products

2,3-Dimethylquinoxaline CAS 2379-55-7 Purity >97.0% (GC) (T)

Maltol CAS 118-71-8 (3-Hydroxy-2-Methyl-4-Pyrone) Purity ≥99.0% (HPLC)

L-Menthol CAS 2216-51-5 Purity >99.5% (GC) Factory

tert-Butylhydroquinone (TBHQ) CAS 1948-33-0 Purity >99.5% (GC) Food Antioxidant Factory

Trimagnesium Dicitrate Nonahydrate CAS 153531-96-5 Magnesium (Mg) 14.5%~16.4%

Saccharin Insoluble CAS 81-07-2 Purity >99.0% (HPLC)

2,3-Butanedione CAS 431-03-8 Purity >99.0% (GC)

Top Selling Products

4-Hydroxy-2-Cyclopentenone CAS 61305-27-9 Purity >95.0% (GC)

2-Amino-4-Chloro-3-Nitropyridine CAS 6980-08-1 Purity ≥98.0% Factory

Iodine CAS 12190-71-5 (Chile) Content ≥99.8% Factory High Quality

(S)-(-)-BINAP CAS 76189-56-5 Purity ≥99.0% (HPLC) E.E ≥99.0% Factory

1-Isopropyl-4-Piperidone CAS 5355-68-0 Purity >97.0% (T)

Ethanesulfonyl Chloride CAS 594-44-5 Purity >99.0% (GC)

2,4-Dihydroxypyridine CAS 626-03-9 Assay >98.0% (HPLC) Factory High Quality

Z-Leu-OH CAS 2018-66-8 N-Cbz-L-Leucine Purity >98.5% (T) Factory

4-Chloro-2-Methoxybenzoic Acid CAS 57479-70-6 Purity >99.0% (HPLC)

Perfluorobutanesulfonyl Fluoride CAS 375-72-4 Purity >97.0% (GC)

2-(Fmoc-Amino)ethyl Bromide CAS 340187-12-4 Purity >98.0% (HPLC)

6-Methyl-3(2H)-Pyridazinone CAS 13327-27-0 Purity >98.0% (HPLC)

The Nobel Prize in Chemistry 2021 Benjamin List and David W.C. MacMillan

New COVID treatments offer hope

Xi presents award to top scientists

The 3rd China International Biological & Chemical Pharmaceutical Industry Conference

Pfizer's Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

The “Summit on COVID-19 Diagnostics & Treatment”

2022.12.04 19:03:06

2022.03.15 17:10:36

2022.02.28 14:46:52

2022.01.28 03:56:33

2021.12.08 23:08:30

2021.12.07 09:26:03

related search